NCT07106749
- Conditions
- Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, +20 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
B Acute Lymphoblastic Leukemia/Lymphoma
Explore clinical trials studying B Acute Lymphoblastic Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
B Acute Lymphoblastic Leukemia/Lymphoma trial results
Not Yet Recruiting
Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors
NCT07539610
- Conditions
- B Acute Lymphoblastic Leukemia/Lymphoma, B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +16 more
- Locations
-
- Institute of Hematology, Chinese Academy of Medical Sciences & Hospital of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China